← Every company
Dexcom Inc Lobbying
What Dexcom Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
DXCM on carbonthat →Disclosed spend
$1.1M
across every filing on file
Filings
10
Years covered
1
Firms retained
4
What it lobbies about
Medicare/MedicaidHealth IssuesMedical/Disease Research/Clinical LabsTrade (domestic/foreign)
10 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | DEXCOM, INC.Health IssuesMedicare/Medicaid | $380K |
| 20262nd Quarter (Apr 1 - June 30) | DEXCOM, INC.Medicare/MedicaidTrade (domestic/foreign) | $370K |
| 20262nd Quarter (Apr 1 - June 30) | CONTINENTAL STRATEGY, LLCHealth IssuesMedical/Disease Research/Clinical Labs | $75K |
| 20261st Quarter (Jan 1 - Mar 31) | CONTINENTAL STRATEGY, LLCHealth IssuesMedical/Disease Research/Clinical Labs | $75K |
| 20262nd Quarter (Apr 1 - June 30) | FARRAGUT PARTNERS LLPMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | FARRAGUT PARTNERS LLPMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | ALSTON & BIRD LLPHealth IssuesMedicare/Medicaid | $40K |
| 20262nd Quarter (Apr 1 - June 30) | BGR GOVERNMENT AFFAIRSMedicare/Medicaid | $40K |
| 20262nd Quarter (Apr 1 - June 30) | ALSTON & BIRD LLPMedicare/MedicaidHealth Issues | $40K |
| 20262nd Quarter (Apr 1 - June 30) | BGR GOVERNMENT AFFAIRSMedicare/Medicaid | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on DXCM
Company overviewEverything on DXCM in one place, with the price.SEC filingsWhat DXCM's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat DXCM's own officers and directors buy and sell.Planned salesSales DXCM insiders have filed notice of.Who owns itEvery manager reporting a position in DXCM.Funds holding itWhich funds and ETFs hold DXCM, and how big a bet.Who lobbies for itThe lobbyists on DXCM's account, and who they worked for.PatentsWhat DXCM is filing at the patent office.